ps1145 and Body-Weight

ps1145 has been researched along with Body-Weight* in 1 studies

Other Studies

1 other study(ies) available for ps1145 and Body-Weight

ArticleYear
Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding.
    American journal of physiology. Endocrinology and metabolism, 2010, Volume: 299, Issue:1

    In peripheral tissues, the link between obesity and insulin resistance involves low-grade inflammation induced by macrophage activation and proinflammatory cytokine signaling. Since proinflammatory cytokines are also induced in the hypothalamus of animals placed on a high-fat (HF) diet and can inhibit neuronal signal transduction pathways required for normal energy homeostasis, hypothalamic inflammation is hypothesized to contribute to the pathogenesis of diet-induced obesity (DIO). We addressed this hypothesis by perturbing the inflammatory milieu of the hypothalamus in adult male Wistar rats using intracerebroventricular (icv) administration of interleukin-4 (IL-4), a Th2 cytokine that promotes alternative activation (M2) of macrophages and microglia. During HF feeding, icv IL-4 administration increased hypothalamic proinflammatory cytokine gene expression and caused excess weight gain. Intracerebroventricular pretreatment with PS1145, an inhibitor of IKKbeta (a key intracellular mediator of inflammatory signaling), blocked both IL-4 effects, suggesting a causal relationship between IL-4-induced weight gain and hypothalamic inflammation. These observations add to growing evidence linking hypothalamic inflammation to obesity pathogenesis.

    Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Energy Metabolism; Heterocyclic Compounds, 3-Ring; Hypothalamus; I-kappa B Kinase; Inflammation; Insulin; Interleukin-4; Leptin; Macrophage Activation; Male; Obesity; Pyridines; Rats; Rats, Wistar; Specific Pathogen-Free Organisms

2010